Multimodal platform powered by robotic intelligence enables delegated testing, delivers data-driven insights, and enhances patient engagement

LA JOLLA, CA — Topcon Healthcare, Inc., today introduced the TERA Dry Eye Imager, a multimodal platform purpose-built to detect, grade, and manage dry eye disease. TERA pairs robotic automation with high-resolution imaging to standardize capture and speed exams. The system integrates corneal topography, pupillometry, and a dedicated dry eye suite with validated clinical grading scales. It assesses both signs and symptoms at the point of care and turns results into clear, actionable guidance for treatment and follow-up.

Innovation should simplify care. TERA standardizes dry eye evaluation and engages patients with clear results that support timely treatment.

Lance Patton, Chief Commercial Officer at Topcon Healthcare, Inc.

Automated Diagnostics Enable Delegation, Speed, and Consistency 

TERA enables practices to delegate dry-eye pretesting with confidence by cutting variability and minimizing staff training time while improving patient throughput. One-touch automated alignment, focus, and capture (with eye tracking where applicable) streamlines acquisition, while guided focus for meibography and tear meniscus heights supports reliable, high-quality images. A rotatable monitor that can be operated from either side of the patient further improves ergonomics and optimizes pre-test space to keep rooms flowing smoothly.

High-Resolution Imaging Empowers Clearer Insights and Confident Decisions

Clinicians get sharper, non-invasive views and a structured, standards-aligned path to pinpoint dry-eye drivers, explain findings, and guide treatment. In line with the DEWS III diagnostic framework,¹ TERA pairs patient-reported symptoms (e.g., OSDI-6) with objective measures such as non-invasive tear break-up time (NIBUT), ocular surface staining, and meibography, while high-resolution color imaging with patented diffused while light technology visualizes the ocular surface and tear film lipid layer. A modern interface with validated grading scales (Efron, JENVIS, Meiboscale) promotes consistent evaluations and clearer patient communication. By turning diagnostic data into a personalized, visual conversation, TERA helps patients better understand their condition and why therapies such as intense pulsed light (IPL) and radiofrequency (RF) may be recommended, while positioning practices as technology-forward leaders in ocular surface care. 

Dry eye care is no longer just about diagnosis; it is about building a service that patients understand and value. TERA helps practices stand out by combining advanced imaging with tools that improve patient education and treatment discussions, creating both better outcomes for patients and new opportunities for practice growth.

Rupe Hansra, OD, Vice President of Professional Affairs at Topcon Healthcare, Inc.

1: TFOS DEWS III: Diagnostic Methodology, American Journal of Ophthalmology, May 30, 2025. doi:10.1016/j.ajo.2025.05.033

About Topcon Healthcare, Inc.
Topcon Healthcare, Inc. is part of Topcon Corporation, a leading provider of digital healthcare solutions. Our vision is to improve access and quality of healthcare while decreasing the cost of care. To achieve this vision, we created Healthcare from the Eye™, a connected care ecosystem using AI-powered disease detection and management applied to noninvasive retinal imaging.

MEDIA CONTACT

Topcon Healthcare, Inc. 
Leslie Amodei
VP, Marketing for Americas
[email protected]